CancerInfo Center
Colon Cancer's Secret Agent
Finding a link to a disease can lead to new ways to diagnose and treat the disease. For colorectal cancer, scientists may have discovered its beginning which could lead to new treatments.
Cervical Screening Recommendations Changing
The current guidelines for cervical cancer screening have been in place since 2003. A governmental task force is expected to modify those recommendations.
Hairdressers May be Your Cancer BFF
You may remember the slogan, "Only your hairdresser knows for sure." In a slight twist on that concept, it may be that your stylist not only knows your true color, but is also your best first line of defense against skin cancer.
A Virus That Does More Good Than Harm
For many people, viruses tend to be thought of as unwelcomed guests. For cancer patients, one virus may actually help pancreatic cancer recovery.
New Target for HER2-Positive Breast Cancer
HER2-positive breast cancer is not only aggressive, but it's difficult to eliminate. A recent discovery has found a molecule that could be targeted with new drugs to treat this treacherous form of breast cancer..
36-Year-Old E! News Anchor has Breast Cancer
She was trying for the third time to get pregnant through in vitro fertilization. Instead, Giuliana Rancic - host of E! News - is being treated for breast cancer.
A Pinch of Ginger Root a Day May Keep Cancer Away
Chicken soup or orange juice may or may not help battle a cold, but natural remedies can be a cheap way to prevent disease. A new study may add ginger root as a natural way to help prevent colon cancer.
Until Death Do You Part
When it comes to death, married men have it easy. While unmarried men are more likely to die in general, this might be particularly true when it comes to dying from cancer.
Beta Blockers Block More than High BP
One type of medication may do the job of two: Control high blood pressure and melanoma tumor growth.
UK Rebuffs Advanced Melanoma Drug
A Bristol-Myers Squibb medication that's approved in the United States and Europe for treating advanced melanoma, has been rejected by the British agency similar to the U.S. Food and Drug Administration (FDA).